VIKING THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67 USD | -2.98% |
|
-9.02% | +260.02% |
| 05-17 | Raymond James Upgrades Viking Therapeutics to Strong Buy From Outperform | MT |
| 05-17 | North American Morning Briefing : The "Everything -2- | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIKING THERAPEUTICS, INC. | Bio Therapeutic Drugs | -2.98% | -9.02% | +260.02% | +174.48% | +699.52% | 7.39B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- VKTX Stock
- Charts Viking Therapeutics, Inc.
- Comparison Chart
